Due to key structural differences resulting from amino acid variations, mouse ACE2 protein does not support efficient SARS-CoV-1 or SARS-CoV-2 binding, presenting a challenge to the use of mice as genetic tools in the study of experimental COVID-19 (49, 50). Here, ACE2 is linked to COVID-19.